Biological
BCG-Denmark
BCG-Denmark is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph phase_4
2
50%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (50.0%)
Phase 42 (50.0%)
Trials by Status
unknown125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic
NCT04542330
unknownphase_4
Trial to Compare BCG-Bulgaria and BCG-Denmark
NCT05397678
completedphase_4
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic
NCT04641858
completedphase_3
Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic
NCT04373291
Clinical Trials (4)
Showing 4 of 4 trials
NCT04542330Phase 3
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic
NCT05397678Phase 4
Trial to Compare BCG-Bulgaria and BCG-Denmark
NCT04641858Phase 4
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic
NCT04373291Phase 3
Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4